Suchergebnisse - "2494G1JF75"

PubPharm (68)

1

Favipiravir, remdesivir, and lopinavir : metabolites, degradation products and their analytical methods

enthalten in: Drug metabolism reviews | 2024

von Hoseininezhad-Namin, M. | Rahimpour, E. | Jouyban, A.

2

Reconsideration of interferon treatment for viral diseases : Lessons from SARS, MERS, and COVID-19

enthalten in: International immunopharmacology | 2023

von Ma, D. | Wang, X. | Li, M. | +2

3

Antivirals for prevention of hepatitis B virus mother-to-child transmission in human immunodeficiency virus positive pregnant women co-infected with hepatitis B virus

enthalten in: The Cochrane database of systematic reviews | 2023

von Ugwu, E. | Eleje, G. | Ugwu, A. | +4

4

Antivirals and the Potential Benefits of Orally Inhaled Drug Administration in COVID-19 Treatment

enthalten in: Journal of pharmaceutical sciences | 2022

von Sahin, G. | Akbal-Dagistan, O. | Culha, M. | +4

5

In Silico Evaluation of Natural Flavonoids as a Potential Inhibitor of Coronavirus Disease

enthalten in: Molecules (Basel, Switzerland) | 2022

von Kashyap, P. | Thakur, M. | Singh, N. | +7

6

Safety profile of COVID-19 drugs in a real clinical setting

enthalten in: European journal of clinical pharmacology | 2022

von Chiu, M. | Bhardwaj, M. | Sah, S.

7

Synthetic Attempts Towards Eminent Anti-viral Candidates of SARS-CoV

enthalten in: Mini reviews in medicinal chemistry | 2022

von Kundu, S. | Sarkar, D.

8

Molnupiravir in COVID-19 : A Scoping Review

enthalten in: Current drug research reviews | 2022

von Kaore, S. | Atal, S.

9

COVID-19 : potential therapeutics for pediatric patients

enthalten in: Pharmacological reports : PR | 2021

von Younis, N. | Zareef, R. | Fakhri, G. | +3

10

Umifenovir in hospitalized moderate to severe COVID-19 patients : A randomized clinical trial

enthalten in: International immunopharmacology | 2021

von Alavi Darazam, I. | Shokouhi, S. | Mardani, M. | +19

1
2
3
4
5
6
7
Nächster »
[7]